Literature DB >> 23117854

Pattern of follow-up care and early relapse detection in breast cancer patients.

Sandra M E Geurts1, Femmie de Vegt, Sabine Siesling, Karin Flobbe, Katja K H Aben, Margriet van der Heiden-van der Loo, André L M Verbeek, Jos A A M van Dijck, Vivianne C G Tjan-Heijnen.   

Abstract

Routine breast cancer follow-up aims at detecting second primary breast cancers and loco regional recurrences preclinically. We studied breast cancer follow-up practice and mode of relapse detection during the first 5 years of follow-up to determine the efficiency of the follow-up schedule. The Netherlands Cancer Registry provided data of 6,509 women, operated for invasive non-metastatic breast cancer in 2003-2004. In a random sample including 144 patients, adherence to follow-up guideline recommendations was studied. Mode of relapse detection was studied in 124 patients with a second primary breast cancer and 160 patients with a loco regional recurrence. On average 13 visits were performed during the first 5 years of the follow-up, whereas nine were recommended. With one, two and three medical disciplines involved, the number of visits was 9, 14 and 18, respectively. Seventy-five percent (93/124) of patients with a second primary breast cancer, 42 % (31/74) of patients with a loco regional recurrence after breast conserving surgery and 28 % (24/86) of patients with a loco regional recurrence after mastectomy had no symptoms at detection. To detect one loco regional recurrence or second primary breast cancer preclinically, 1,349 physical examinations versus 262 mammography and/or MRI tests were performed. Follow-up provided by only one discipline may decrease the number of unnecessary follow-up visits. Breast imaging plays a major and physical examination a minor role in the early detection of second primary breast cancers and loco regional recurrences. The yield of physical examination to detect relapses early is low and should therefore be minimised.

Entities:  

Mesh:

Year:  2012        PMID: 23117854     DOI: 10.1007/s10549-012-2297-9

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  15 in total

Review 1.  Overuse of Health Care Services in the Management of Cancer: A Systematic Review.

Authors:  Shrujal S Baxi; Minal Kale; Salomeh Keyhani; Benjamin R Roman; Annie Yang; Antonio P Derosa; Deborah Korenstein
Journal:  Med Care       Date:  2017-07       Impact factor: 2.983

2.  Surveillance Imaging vs Symptomatic Recurrence Detection and Survival in Stage II-III Breast Cancer (AFT-01).

Authors:  Jessica R Schumacher; Heather B Neuman; Menggang Yu; David J Vanness; Yajuan Si; Elizabeth S Burnside; Kathryn J Ruddy; Ann H Partridge; Deborah Schrag; Stephen B Edge; Ying Zhang; Elizabeth A Jacobs; Jeffrey Havlena; Amanda B Francescatti; David P Winchester; Daniel P McKellar; Patricia A Spears; Benjamin D Kozower; George J Chang; Caprice C Greenberg
Journal:  J Natl Cancer Inst       Date:  2022-10-06       Impact factor: 11.816

3.  A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01).

Authors:  Jessica R Schumacher; Heather B Neuman; George J Chang; Benjamin D Kozower; Stephen B Edge; Menggang Yu; David J Vanness; Yajuan Si; Elizabeth A Jacobs; Amanda B Francescatti; Patricia A Spears; Jeffrey Havlena; Taiwo Adesoye; Daniel McKellar; David Winchester; Elizabeth S Burnside; Caprice C Greenberg
Journal:  Ann Surg Oncol       Date:  2018-05-17       Impact factor: 5.344

4.  Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients.

Authors:  Annemieke Witteveen; Ingrid M H Vliegen; Gabe S Sonke; Joost M Klaase; Maarten J IJzerman; Sabine Siesling
Journal:  Breast Cancer Res Treat       Date:  2015-07-11       Impact factor: 4.872

5.  Shifting breast cancer surveillance from current hospital setting to a community based setting: a cost-effectiveness study.

Authors:  Kelly M de Ligt; Annemieke Witteveen; Sabine Siesling; Lotte M G Steuten
Journal:  BMC Cancer       Date:  2018-01-24       Impact factor: 4.430

6.  Open access follow-up care for early breast cancer: a randomised controlled quality of life analysis.

Authors:  M N Kirshbaum; J Dent; J Stephenson; A E Topping; V Allinson; M McCoy; S Brayford
Journal:  Eur J Cancer Care (Engl)       Date:  2016-09-26       Impact factor: 2.520

Review 7.  Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review.

Authors:  Isabella Sperduti; Patrizia Vici; Nicola Tinari; Teresa Gamucci; Michele De Tursi; Giada Cortese; Antonino Grassadonia; Stefano Iacobelli; Clara Natoli
Journal:  J Exp Clin Cancer Res       Date:  2013-11-11

Review 8.  Follow-up care for breast cancer survivors: improving patient outcomes.

Authors:  Ishveen Chopra; Avijeet Chopra
Journal:  Patient Relat Outcome Meas       Date:  2014-08-30

9.  Developing an aftercare decision aid; assessing health professionals' and patients' preferences.

Authors:  Linda Klaassen; Carmen Dirksen; Liesbeth Boersma; Ciska Hoving
Journal:  Eur J Cancer Care (Engl)       Date:  2017-07-20       Impact factor: 2.520

10.  Risk-based breast cancer follow-up stratified by age.

Authors:  Annemieke Witteveen; Jan W M Otten; Ingrid M H Vliegen; Sabine Siesling; Judith B Timmer; Maarten J IJzerman
Journal:  Cancer Med       Date:  2018-09-11       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.